Cassone, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 5.208
EU - Europa 2.487
AS - Asia 721
OC - Oceania 67
SA - Sud America 48
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.571
Nazione #
US - Stati Uniti d'America 5.122
IT - Italia 711
GB - Regno Unito 643
SE - Svezia 372
CN - Cina 194
DE - Germania 180
HK - Hong Kong 171
FI - Finlandia 106
UA - Ucraina 95
FR - Francia 94
JP - Giappone 83
TR - Turchia 81
BG - Bulgaria 69
IE - Irlanda 60
AU - Australia 59
CA - Canada 50
IN - India 44
LT - Lituania 34
PK - Pakistan 32
VN - Vietnam 29
TN - Tunisia 26
MX - Messico 24
KR - Corea 20
PL - Polonia 18
MY - Malesia 17
RU - Federazione Russa 17
NL - Olanda 16
AR - Argentina 15
BZ - Belize 12
PE - Perù 12
HU - Ungheria 11
BE - Belgio 10
ES - Italia 10
IR - Iran 10
NZ - Nuova Zelanda 8
PT - Portogallo 8
BR - Brasile 7
CO - Colombia 7
RO - Romania 7
SG - Singapore 6
AT - Austria 5
JO - Giordania 5
PH - Filippine 5
TW - Taiwan 5
CL - Cile 4
DK - Danimarca 4
EU - Europa 4
ID - Indonesia 4
IL - Israele 4
LU - Lussemburgo 4
RS - Serbia 4
SA - Arabia Saudita 4
EC - Ecuador 3
EG - Egitto 3
BD - Bangladesh 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
ZA - Sudafrica 2
A1 - Anonimo 1
CY - Cipro 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
MM - Myanmar 1
NO - Norvegia 1
Totale 8.571
Città #
Fairfield 853
Chandler 507
Ashburn 473
Southend 451
Woodbridge 341
Houston 281
Seattle 267
Nyköping 264
Wilmington 259
Cambridge 240
Ann Arbor 215
Hong Kong 161
Jacksonville 142
Dearborn 110
Modena 110
San Diego 95
New York 89
Helsinki 88
Sofia 69
Princeton 68
Beijing 64
Redwood City 64
Milan 52
London 50
Perth 46
Bremen 39
Eugene 36
Izmir 36
Dublin 32
Rome 31
Shanghai 27
Falls Church 25
San Jose 25
Los Angeles 23
Tokyo 22
Bologna 20
Dong Ket 18
Boardman 15
Reggio Nell'emilia 13
Belize City 12
Catania 12
Bari 11
Chicago 11
Moscow 11
Norwalk 11
Ottawa 11
Buffalo 10
Menlo Park 10
Mumbai 10
Toronto 10
Brussels 9
Gangnam-gu 9
Hamilton 9
Hounslow 9
Las Vegas 9
Cagliari 8
Guangzhou 8
Kilburn 8
Louisville 8
Debrecen 7
Frankfurt am Main 7
Hangzhou 7
Parma 7
Phoenix 7
San Francisco 7
Ahmedabad 6
Atlanta 6
Bogotá 6
Casarano 6
Chiclayo 6
Chiswick 6
Columbus 6
Gloucester 6
Istanbul 6
Nagoya 6
Ankara 5
Caserta 5
Cremona 5
Duncan 5
Hefei 5
Ho Chi Minh City 5
Kolkata 5
Manchester 5
Monza 5
Nanjing 5
Napoli 5
Saint Louis 5
Shijiazhuang 5
Udine 5
Christchurch 4
Credaro 4
Dallas 4
Delhi 4
Edmonton 4
Esslingen am Neckar 4
Florence 4
Fremont 4
Impruneta 4
Liverpool 4
Livorno 4
Totale 6.133
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 795
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 253
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 241
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 224
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 203
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 202
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 201
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 200
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 196
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 192
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 173
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 170
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 167
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 165
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 161
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 157
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 146
Severe alopecia complicating systemic sclerosis 143
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 142
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 142
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 140
Nailfold videocapillaroscopy in antisynthetase syndrome 138
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 136
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 129
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 127
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 125
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 124
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 124
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 123
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 122
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 122
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 117
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 113
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 111
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 110
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 110
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 104
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 102
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 102
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 102
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 100
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 86
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 86
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 82
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 78
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 73
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 73
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 72
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 70
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 70
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 67
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 67
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 65
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 64
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 64
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 63
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 61
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 60
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 58
Fibrosing interstitial lung disease in primary Sjogren syndrome 57
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 52
Rheumatoid arthritis related interstitial lung disease 50
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 48
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 46
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 44
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 41
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 39
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 38
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 37
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 33
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al 29
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 27
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 22
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 21
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 20
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 18
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 17
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 16
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 14
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 14
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 14
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 14
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 13
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 11
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 8
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 8
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 7
Granuloma annulare as a possible new adverse effect of topiramate 6
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 4
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 3
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 2
Personalized Medicine and Machine Learning: A Roadmap for the Future 2
Totale 8.788
Categoria #
all - tutte 43.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019216 0 0 0 0 0 0 0 0 0 0 90 126
2019/20201.229 109 51 33 63 104 180 183 140 154 91 68 53
2020/20211.900 133 65 134 138 196 135 225 197 184 211 143 139
2021/20221.747 144 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.343 68 89 75 232 219 125 129 254 47 54 51 0
Totale 8.788